Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 21.31% | -11.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.31% | -11.65% | |||
| Cost of Revenue | 41.98% | -35.06% | |||
| Gross Profit | 15.92% | -2.49% | |||
| SG&A Expenses | -3.16% | -25.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.44% | -13.22% | |||
| Operating Income | 139.51% | -3.28% | |||
| Income Before Tax | 135.00% | -2.63% | |||
| Income Tax Expenses | 147.73% | -60.61% | |||
| Earnings from Continuing Operations | 132.18% | 44.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 132.18% | 44.48% | |||
| EBIT | 139.51% | -3.28% | |||
| EBITDA | 120.26% | -5.94% | |||
| EPS Basic | 131.71% | 44.04% | |||
| Normalized Basic EPS | 134.55% | -2.94% | |||
| EPS Diluted | 132.73% | 44.24% | |||
| Normalized Diluted EPS | 135.09% | -2.76% | |||
| Average Basic Shares Outstanding | 0.20% | 0.32% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||